Risk-Benefit of IBD Drugs: A Physicians and Patients Survey.
Ferdinando D'AmicoSophie VieujeanBenedicte CaronLaurent Peyrin-BirouletSilvio DanesePublished in: Journal of clinical medicine (2023)
Physicians and patients have different priorities in evaluating the benefit-risk balance of a new therapy.